Jennifer W. Leiding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer W. Leiding has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Panida Sriaroon
University of South Florida
3 shared publications Aleksandra Petrovic
Blood and Bone Marrow Transplant Program, All Children's Hospital, St Petersburg, Florida
2 shared publications- Lisa Forbes Satter
Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
2 shared publications Steven M. Holland
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
2 shared publicationsAlexandra F. Freeman
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md
1 shared publicationAmy P. Hsu
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
1 shared publication
Latest Publications
- 5 November 2020
- Published by Springer Nature
- p. 294-296
Evaluation of Suspected Immunodeficiency, Genetic Testing
- 5 November 2020
- Published by Springer Nature
- p. 294-296
Evaluation of Suspected Immunodeficiency, Genetic Testing
- 5 November 2020
- Published by Springer Nature
- p. 392-398
Innate Immune Defects, Clinical Presentation
- 5 November 2020
- Published by Springer Nature
- p. 292-293
Evaluation of Suspected Immunodeficiency, Flow Cytometry
- 5 November 2020
- Published by Springer Nature
- p. 292-293
Evaluation of Suspected Immunodeficiency, Flow Cytometry
- 5 November 2020
- Published by Springer Nature
- p. 458-460
Management of Immunodeficiency, Bone Marrow Transplantation
- 5 November 2020
- Published by Springer Nature
- p. 458-460
Management of Immunodeficiency, Bone Marrow Transplantation
- 5 November 2020
- Published by Springer Nature
- p. 471-474
Management of Immunodeficiency: Gene Therapy
- Open Access
- 22 April 2020
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8, 117
Brain Abscess as Severe Presentation of Specific Granule Deficiency
Severe invasive infections such as brain abscess in a child should prompt an immune evaluation. Specific granule deficiency (SGD) is a rare morphologic neutrophil granular defect characterized by reduced granules within neutrophils, absence of granule proteins, and bilobed nuclei. Patients are susceptible to invasive bacterial infections and Candida infections. Mutations in CCAT/enhancer binding protein epsilon (C/EBP-ε) are the most commonly described cause of SGD. The dihydrorhodamine assay is a quantitative and qualitative functional test that determines the oxidative burst and killing potential of neutrophils. Herein, we describe two brothers with specific granule deficiency. The index patient had a history of cellulitis twice in the first year of life and then presented at 13 months age with fever, leukocytosis, and right sided weakness. A large space occupying brain abscess was diagnosed. He underwent surgical drainage and cultures yielded Staphylococcus aureus. This infection prompted his diagnosis. His older brother had also been healthy but too had had several episodes of cellulitis. His brother too was diagnosed with SGD when family genetic screening was performed. Evaluation of the index patient included a peripheral smear that showed absent neutrophil granule presence. Forward and side scatter of whole blood via flow cytometry revealed a loss of granularity of neutrophils. A DHR was performed to rule out functional killing defects. After stimulation with PMA, neutrophils from the index patient displayed three distinct patterns, two with abnormal oxidase production, and two with reduced function. Both patients were ultimately diagnosed with SGD and remain on lifelong anti-bacterial prophylaxis. Diagnosis of SGD relies on establishing reduced or absent granularity within neutrophils. Lifelong anti-bacterial and anti-fungal prophylaxis is indicated. Hematopoietic cell transplantation has also been curative.
- 22 April 2020
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8, 117
Open AccessBrain Abscess as Severe Presentation of Specific Granule Deficiency
Severe invasive infections such as brain abscess in a child should prompt an immune evaluation. Specific granule deficiency (SGD) is a rare morphologic neutrophil granular defect characterized by reduced granules within neutrophils, absence of granule proteins, and bilobed nuclei. Patients are susceptible to invasive bacterial infections and Candida infections. Mutations in CCAT/enhancer binding protein epsilon (C/EBP-ε) are the most commonly described cause of SGD. The dihydrorhodamine assay is a quantitative and qualitative functional test that determines the oxidative burst and killing potential of neutrophils. Herein, we describe two brothers with specific granule deficiency. The index patient had a history of cellulitis twice in the first year of life and then presented at 13 months age with fever, leukocytosis, and right sided weakness. A large space occupying brain abscess was diagnosed. He underwent surgical drainage and cultures yielded Staphylococcus aureus. This infection prompted his diagnosis. His older brother had also been healthy but too had had several episodes of cellulitis. His brother too was diagnosed with SGD when family genetic screening was performed. Evaluation of the index patient included a peripheral smear that showed absent neutrophil granule presence. Forward and side scatter of whole blood via flow cytometry revealed a loss of granularity of neutrophils. A DHR was performed to rule out functional killing defects. After stimulation with PMA, neutrophils from the index patient displayed three distinct patterns, two with abnormal oxidase production, and two with reduced function. Both patients were ultimately diagnosed with SGD and remain on lifelong anti-bacterial prophylaxis. Diagnosis of SGD relies on establishing reduced or absent granularity within neutrophils. Lifelong anti-bacterial and anti-fungal prophylaxis is indicated. Hematopoietic cell transplantation has also been curative.
- 8 March 2019
- Published by Springer Nature
- p. 1-3
Management of Immunodeficiency, Bone Marrow Transplantation
- 8 March 2019
- Published by Springer Nature
- p. 1-3
Management of Immunodeficiency, Bone Marrow Transplantation
- 1 March 2019
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (3) , 761-773
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases
- 1 March 2019
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (3) , 761-773
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases
- 1 March 2019
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (3) , 819-823
Antibiotic Prophylaxis for Dental Treatment in Patients with Immunodeficiency
- 1 March 2019
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (3) , 819-823
Antibiotic Prophylaxis for Dental Treatment in Patients with Immunodeficiency
- 1 November 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 142 (5) , 1665-1669
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
- 1 November 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 142 (5) , 1665-1669
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations